InVivo Therapeutics Corp — Form D
InVivo Therapeutics Corp of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-09-03. The offering totals $500K, of which $300K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-09-03
- Form: D
- Accession: 0001500550-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $500K
- Amount sold: $300K
- Remaining: $200K
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2010-08-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-147272
Issuer
- Name: InVivo Therapeutics Corp
- CIK: 0001500550
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: 617-475-1520
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| George J Nolen | Director | Cambridge, MA |
| Christi M Pedra | Director | Cambridge, MA |
| Frank M Reynolds | Director | Cambridge, MA |
| Richard J Roberts | Director | Cambridge, MA |
| Sean F Moran | Executive Officer | Cambridge, MA |
| Christopher F Pritchard | Executive Officer | Cambridge, MA |
| Frank M Reynolds | Executive Officer | Cambridge, MA |
More